Astrocytoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
::* Congenital conditions | ::* Congenital conditions | ||
::* [[Li-Fraumeni syndrome]] | ::* [[Li-Fraumeni syndrome]] | ||
:* Autosomal dominant conditions | :* [[Autosomal dominant]] conditions | ||
::* [[Melanoma]]-[[astrocytoma]] syndrome | ::* [[Melanoma]]-[[astrocytoma]] syndrome | ||
::* [[Neurofibromatosis type 1]] | ::* [[Neurofibromatosis type 1]] | ||
::* [[Neurofibromatosis type 2]] | ::* [[Neurofibromatosis type 2]] | ||
:* Autosomal recessive conditions | :* [[Autosomal recessive]] conditions | ||
::* [[Turcot syndrome]] | ::* [[Turcot syndrome]] | ||
Revision as of 15:09, 24 August 2015
|
Astrocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Study |
|
Astrocytoma risk factors On the Web |
|
American Roentgen Ray Society Images of Astrocytoma risk factors |
|
Risk calculators and risk factors for Astrocytoma risk factors |
Overview
Common risk factors in the development of astrocytoma are prior exposure to radiation therapy to the brain and congenital diseases. Invalid parameter in <ref> tag
Risk Factors
- Possible risk factor for astrocytoma includes the following.
- Past radiation therapy to the brain
- Genetic predisposition
- Congenital conditions
- Li-Fraumeni syndrome
- Autosomal dominant conditions
- Autosomal recessive conditions